Because of 1 H-MRS results supporting glutamate reductions secondary to antipsychotics, agents developed to increase glutamate, like NMDA agonists, would be unlikely to have a therapeutic role (perhaps beyond correcting some side-effects of D 2 blockers)
Promotion of Angiogenesis: BPC-157 activates vascular endothelial growth factor (VEGF) and nitric oxide (NO) pathways, stimulating new capillary formation and improving blood supply to damaged tissues
This dual approach delivers the peptide both systemically and directly to follicles, addressing hair loss from multiple directions simultaneously
Unlike some alternatives, it does not increase appetite, cortisol, or prolactin
Before we dive into temperature, lets get crystal clear on what were dealing with
(PubMed) Grothe J, Riethmuller J, Tschurtz SM, et al